Real‐World Effectiveness of Switching to Oral or Infusion Versus Injectable Disease‐Modifying Therapy in Pediatric Multiple Sclerosis

Journal:
Annals of Neurology
Published:
DOI:
10.1002/ana.78086
Affiliations:
20
Authors:
27
Institutions Authors Share
Cleveland Clinic, United States of America (USA)
3.000000
0.11
NYU Langone Health, United States of America (USA)
3.000000
0.11
University of California, San Francisco (UCSF), United States of America (USA)
3.000000
0.11
Health Sciences Center (HSC), Utah, United States of America (USA)
2.000000
0.07
Boston Children's Hospital (BCH), United States of America (USA)
2.000000
0.07
The University of Alabama at Birmingham (UAB), United States of America (USA)
2.000000
0.07
Mayo Clinic, United States of America (USA)
2.000000
0.07
Loma Linda University (LLU), United States of America (USA)
1.000000
0.04
Massachusetts General Hospital (MGH), United States of America (USA)
1.000000
0.04
University of California, San Diego (UC San Diego), United States of America (USA)
1.000000
0.04
Texas Children's Hospital, BCM, United States of America (USA)
1.000000
0.04
Washington University in St. Louis (WUSTL), United States of America (USA)
1.000000
0.04
The University of Utah (Utah), United States of America (USA)
1.000000
0.04
University of Colorado Anschutz Medical Campus (CU Anschutz), United States of America (USA)
1.000000
0.04
University at Buffalo, The State University of New York (SUNY UB), United States of America (USA)
1.000000
0.04
Dell Children’s Medical Center, Seton Healthcare Family, United States of America (USA)
0.500000
0.02
The University of Texas at Austin (UT Austin), United States of America (USA)
0.500000
0.02
St. Michael's Hospital, Canada
0.500000
0.02
University of Toronto (U of T), Canada
0.500000
0.02